Table I.
Results of cytology screening, HR HPV testing and histology of adjacent squamous mucosa in association with cervical AIS.
| Cases | Age (years) | Cytological results | Squamous mucosa | HPV types |
|---|---|---|---|---|
| 1 | 23 | HSIL | CIN 3 | 16+18/45 |
| 2 | 23 | LSIL | CIN 3 | - |
| 3 | 25 | LSIL | CIN 1 | 16 |
| 4 | 26 | LSIL | CIN 3 | 16+18/45+33/53/58 |
| 5 | 26 | ASCUS | CIN 2 | 18/45+59 |
| 6 | 26 | ASCUS | CIN 1 | 16+33/53/58+56 |
| 7 | 30 | ASCUS | CIN 1 | - |
| 8 | 31 | ASCUS | CIN 3 | 18/45 |
| 9 | 32 | ASCUS | CIN 3 | 18/45+59 |
| 10 | 32 | WNL | CIN 3 | - |
| 11 | 32 | WNL | CIN 2 | - |
| 12 | 32 | AGUS | CIN 3 | - |
| 13 | 32 | ASCUS | CIN 1 | 18/45 |
| 14 | 33 | AGUS | CIN 3 | 18/45 |
| 15 | 33 | AGUS | Normal | 18/45 |
| 16 | 34 | HSIL | CIN 3 | 16 |
| 17 | 36 | ASCUS | CIN 2 | 16 |
| 18 | 38 | ASCUS | CIN 3 | 18/45 |
| 19 | 39 | HSIL | CIN 1 | - |
| 20 | 40 | AGUS | CIN 1 | 18/45 |
| 21 | 41 | ASCUS | CIN 3 | Negative |
| 22 | 42 | ASCUS | CIN 3 | 18/45 |
| 23 | 42 | AIS | CIN 3 | 18/45 |
| 24 | 43 | AGUS | Normal | 18/45 |
| 25 | 44 | Not available | Normal | - |
| 26 | 44 | HSIL | CIN 3 | 18/45 |
| 27 | 44 | HSIL | CIN 2 | - |
| 28 | 44 | AGUS | CIN 3 | 18/45 |
| 29 | 46 | Not available | CIN 3 | - |
| 30 | 47 | AIS | CIN 1 | - |
| 31 | 60 | Not available | CIN 3 | 18/45 |
| 32 | 61 | Not available | CIN 3 | 18/45 |
HPV, human papillomavirus; AGUS, atypical glandular cells of undetermined significance; AIS, adenocarcinoma in situ; ASCUS, atypical glandular cells of undetermined significance; LSIL, low-grade squamous intraepithelial lesions; HSIL, high-grade squamous intraepithelial lesions; CIN, cervical intraepithelial neoplasia; WNL, within normal limits.